Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was incorporated in 2018 and is headquartered in Petah Tikva, Israel.

Period	ROE
2020-12-31	-18.99%
2021-12-31	-21.36%
2022-12-31	-44.70%
2023-12-31	-37.30%
2024-12-31	-28.25%
2025-12-31	-53.69%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NNOX	$1.67	-3.47%	1.49M
3
4
5

NANO-X IMAGING LTD (NNOX) Return on Equity (ROE)

ROE & ROA Data

Get NANO-X IMAGING LTD Data in Excel

More NNOX Financial Data